In Vitro Model Demonstrates Varying Ablation Efficiency Among Holmium:YAG Moses, Pulsed-Thulium:YAG, and Thulium Fiber Laser Systems in Calcium Oxalate and Uric Acid Stones
Background/Objectives: Emerging laser systems in endourology require further head-to-head trials to evaluate their ablation efficiency, or the amount of stone treated per energy spent. To answer this question, we built an in vitro model to compare stone ablation efficiency between the holmium:YAG with pulse modulation (Moses), pulsed thulium:YAG (pTm:YAG), and Thulium Fiber Laser (TFL) using dusting and fragmentation settings on uric acid (UA) and calcium oxalate monohydrate (COM) stones. Methods: We built an in vitro system with 24 UA and 18 COM stones fixed onto Petri dishes and submerged into warm saline. We used 200-micron laser fibers with settings of 0.3 J × 30 Hz for dusting and 1 J × 10 Hz for fragmenting. Each laser was fired while contacting the stone for 1 s per trial. Ablated stone volume was measured using Optical Coherence Tomography (OCT). A one-way Analysis of Variance (ANOVA) was conducted to determine differences in mean efficiency of laser fibers at different settings, with significance assessed at p < 0.05. Results: In total, 81 craters created by laser ablation were detected via OCT. When fragmenting UA stones, pTm:YAG was the most efficient, averaging 116.8 mm3/kJ, compared to 110.8 for TFL and 51.4 for Moses (p = 0.0003). There were no differences on the dusting setting for UA. TFL was the most efficient in fragmenting COM stones with 69.2 mm3/kJ, compared to 49.5 for pTm:YAG and 32.7 for Moses (p = 0.0024). Finally, pTm:YAG was the most efficient for dusting COM stones, with 30.5 mm3/kJ, compared to 23.8 for TFL and 14.5 (p = 0.0175). Conclusions: Pulsed Tm:YAG exhibited the most efficient fragmentation of UA stones and dusting of COM stones, while TFL was the most efficient for fragmenting COM stones.
Authors
- Tyler J. Sheetz (ORCID: https://orcid.org/0000-0002-4440-1477)
- Seth K. Bechis (ORCID: https://orcid.org/0000-0002-2430-2893)
- Nitesh Katta (ORCID: https://orcid.org/0000-0001-8097-5489)
- Bruce M. Gao (ORCID: https://orcid.org/0000-0002-0290-4316)
- Roshan M. Patel (ORCID: https://orcid.org/0000-0002-0542-8992)
- Sirpi Nackeeran (ORCID: https://orcid.org/0000-0002-6950-2645)
- Luke K. Griffiths (ORCID: https://orcid.org/0000-0002-6305-7173)
- Seyedamirvala Saadat (ORCID: https://orcid.org/0009-0009-1720-1507)
- Jamie L. Finegan (ORCID: https://orcid.org/0009-0009-0870-4356)
- Yezan F. Hadidi
- Harel C. Sims (ORCID: https://orcid.org/0009-0004-4765-2759)
- V Nguyen
- Aymon Ali
Institutions
- University of California, Irvine (US)
- University of California System (US)
- University of California San Diego (US)
- University of California, Irvine Medical Center (US)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-11-11
- DOI
- https://doi.org/10.3390/jcm15228803
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00